Antiviral Power
Zidovudine (AZT) is the first antiviral treatment shown to effectively block FIV & FeLV virus replication, helping halt disease progression.
Improves quality of life
Studies show AZT can reduce viral load and improve energy, appetite, and overall health in cats infected with FIV and FeLV.
Safe and Reliable
Formulated specifically for cats with precise dosing to ensure maximum safety and tolerability.
Petvital® Zidovudine (AZT) Tablets for Cats
FIV & FeLV Treatment
Order Now
Zidovudine (AZT) vs Traditional FIV Supportive Therapy
| Category | Traditional FIV Supportive Therapy | Zidovudine (AZT) |
|---|---|---|
| Treatment Goal | Supportive care: manage opportunistic infections, maintain quality of life, and slow immune decline. | Antiviral therapy: directly inhibit FIV reverse transcriptase, reduce viral load, and restore immune function. |
| Core Concept | "Manage + Support" — addresses complications without targeting the virus itself. | "Suppress + Restore" — targets viral replication at its source, aiming to control disease progression. |
| Therapeutic Nature | Passive symptom management. | Active antiviral intervention with proven reverse transcriptase inhibition. |
| Clinical Effect | Improves comfort and manages symptoms but does not reduce viral burden or restore CD4/CD8 ratio. | Significantly reduces plasma viral load, improves CD4/CD8 ratio, and extends life expectancy with better quality of life. |
Treatment Goal
▼Traditional Therapy
Supportive care: manage opportunistic infections, maintain quality of life, and slow immune decline.
Zidovudine (AZT)
Antiviral therapy: directly inhibit FIV reverse transcriptase, reduce viral load, and restore immune function.
Core Concept
▼Traditional Therapy
"Manage + Support" — addresses complications without targeting the virus itself.
Zidovudine (AZT)
"Suppress + Restore" — targets viral replication at its source, aiming to control disease progression.
Therapeutic Nature
▼Traditional Therapy
Passive symptom management.
Zidovudine (AZT)
Active antiviral intervention with proven reverse transcriptase inhibition.
Clinical Effect
▼Traditional Therapy
Improves comfort and manages symptoms but does not reduce viral burden or restore CD4/CD8 ratio.
Zidovudine (AZT)
Significantly reduces plasma viral load, improves CD4/CD8 ratio, and extends life expectancy with better quality of life.
Zidovudine (AZT) vs Traditional FeLV Supportive Therapy
| Category | Traditional FeLV Supportive Therapy | Zidovudine (AZT) |
|---|---|---|
| Treatment Goal | Supportive care: relieve symptoms, maintain immune function, and reduce secondary infections. | Antiviral therapy: directly suppress FeLV replication, delaying or reversing disease progression. |
| Core Concept | "Relief + Support" — focuses on complications, without addressing the viral source. | "Control + Intervention" — targets the virus itself, aiming to block or clear FeLV activity. |
| Therapeutic Nature | Passive and supportive. | Active antiviral action. |
| Clinical Effect | Improves clinical condition but does not affect viral load. | Significantly reduces viremia and slows viral replication. |
Treatment Goal
▼Traditional Therapy
Supportive care: relieve symptoms, maintain immune function, and reduce secondary infections.
Zidovudine (AZT)
Antiviral therapy: directly suppress FeLV replication, delaying or reversing disease progression.
Core Concept
▼Traditional Therapy
"Relief + Support" — focuses on complications, without addressing the viral source.
Zidovudine (AZT)
"Control + Intervention" — targets the virus itself, aiming to block or clear FeLV activity.
Therapeutic Nature
▼Traditional Therapy
Passive and supportive.
Zidovudine (AZT)
Active antiviral action.
Clinical Effect
▼Traditional Therapy
Improves clinical condition but does not affect viral load.
Zidovudine (AZT)
Significantly reduces viremia and slows viral replication.